Dianthus Therapeutics
Clinical trials sponsored by Dianthus Therapeutics, explained in plain language.
-
Experimental drug aims to help people with rare nerve disease
Disease control Recruiting nowThis study is testing whether an experimental drug called DNTH103 is safe and effective for adults with multifocal motor neuropathy (MMN), a rare condition that causes muscle weakness. The trial will involve 36 participants who are already receiving standard immunoglobulin treatm…
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC
-
Major trial tests new drug to control debilitating nerve disease
Disease control Recruiting nowThis Phase 3 study aims to see if the investigational drug DNTH103 is effective and safe for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder that damages nerves and causes weakness. The trial will enroll 480 participants and compar…
Phase: PHASE3 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC